Portrait of Larson, John B.

Larson, John B.

U.S. Representative CT-1 Democratic Party

Congressional stock trade history disclosed under the STOCK Act, as filed.

Disclosed trades
34
Buys / sells
0% / 100%
Last trade
Dec 18, 2019
Last filing
Jan 31, 2020

Latest disclosed trades

Latest 10 of 34
Ticker Type Traded
SBUX Sell Dec 18, 2020
— Allergan Inc [CS] F ILINg S TATu Sell Dec 18, 2019
TMO Sell Dec 18, 2019
MDLZ Sell Dec 18, 2019
STZ Sell Dec 18, 2019
ROLL Sell Dec 18, 2019
JPM Sell Dec 18, 2019
IQV Sell Dec 18, 2019
ILMN Sell Dec 18, 2019
WY Sell Dec 18, 2019

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window.

Larson, John B. stock trade activity

FilingIQ has indexed 34 congressional stock trade disclosures for Larson, John B.. The most recent disclosed transaction is dated Dec 18, 2019.

Across the full history, 0 purchases and 34 sales have been disclosed under the STOCK Act.

Top tickers traded by Larson, John B.

Frequently asked

How many stock trades has Larson, John B. disclosed?
FilingIQ tracks 34 Periodic Transaction Report disclosures for Larson, John B., with the most recent dated Dec 18, 2019. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Larson, John B. a net buyer or net seller?
Across the disclosed trade history, 0 (0%) were purchases and 34 (100%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Larson, John B. come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.